Causes and Predisposing Factors of De Novo Tumors in Our Series of Liver Transplant Recipients

被引:14
|
作者
Tallon Aguilar, L. [1 ]
Barrera Pulido, L. [1 ]
Bernal Bellido, C. [1 ]
Pareja Ciuro, F. [1 ]
Suarez Artacho, G. [1 ]
Alamo Martinez, J. M. [1 ]
Garcia Gonzalez, I. [1 ]
Gomez Bravo, M. A. [1 ]
Bernardos Rodriguez, A. [1 ]
机构
[1] Hosp Univ Virgen Rocio, Liver Transplant & Hepatobiliopancreat Surg Unit, Gen & Gastrointestinal Surg Dept, Seville, Spain
关键词
D O I
10.1016/j.transproceed.2009.05.012
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Introduction. Liver transplant recipients suffer a high risk of developing cancer, mainly as a consequence of immunosuppressant treatment, although a variety of other factors are involved. Our purposes were to evaluate the frequency of de novo tumours and to determine predisposing factors. Material and Methods. We analyzed all of the transplantations performed during 1990, with a total of almost 700 cases. We analyzed the frequency of de novo tumors, their location, time since transplantation, survival, and recurrence rates and factors that may influence their appearance. Results. The series included 64 cases in 50 patients with a frequency of 7%. Skin tumors were the most frequent (39.06%), followed by those in the otolaryngologic (ear, nose, and throat) region (15.62%) and the lung (14.06%). The average time to progression between the transplantation and diagnosis was less than 4 years (47.74 months). The recurrence rate was 16%. The factors with the greatest influence on their appearance were age and gender of the recipient, alcohol consumption, and Child-Pugh score. Plasma transfusion was statistically, although not clinically, significant. Discussion. Our frequency of de novo tumors was consistent with that described in the literature. Despite some factors that influence their appearance, the main predisposing factor was immunosuppression and its duration.
引用
收藏
页码:2453 / 2454
页数:2
相关论文
共 50 条
  • [21] Survival after the diagnosis of de novo malignancy in liver transplant recipients
    Taborelli, Martina
    Piselli, Pierluca
    Ettorre, Giuseppe Maria
    Baccarani, Umberto
    Burra, Patrizia
    Lauro, Augusto
    Galatioto, Laura
    Rendina, Maria
    Shalaby, Sarah
    Petrara, Raffaella
    Nudo, Francesco
    Toti, Luca
    Fantolall, Giovanni
    Cimaglia, Claudia
    Agresta, Alessandro
    Vennarecci, Giovanni
    Pinna, Antonio Daniele
    Gruttadauria, Salvatore
    Risaliti, Andrea
    Di Leo, Alfredo
    Rossi, Massimo
    Tisone, Giuseppe
    Zambonill, Fausto
    Serraino, Diego
    INTERNATIONAL JOURNAL OF CANCER, 2019, 144 (02) : 232 - 239
  • [22] De novo aortopathy and cardiovascular outcomes in paediatric liver transplant recipients
    Huang, James G.
    Lim, Terence
    Quek, Swee-Chye
    Quak, Seng-Hock
    Aw, Marion M.
    CARDIOLOGY IN THE YOUNG, 2018, 28 (08) : 986 - 994
  • [23] De novo cancer in transplant recipients
    Kim, MS
    Kim, SI
    Kim, YS
    Oh, CK
    Park, K
    TRANSPLANTATION PROCEEDINGS, 1996, 28 (03) : 1651 - 1652
  • [24] Incidence and Risk Factors of Post-Transplant De Novo Malignancies in Recipients of Liver Transplant: A Nationwide Survey in Taiwan.
    Yeh, Chun Chieh
    Liao, Chien Chang
    Yang, Horng Ren
    Jeng, Long Bin
    LIVER TRANSPLANTATION, 2013, 19 : S291 - S291
  • [25] Sotrastaurin single-dose pharmacokinetics in de novo liver transplant recipients
    Kovarik, John M.
    Neuhaus, Peter
    Cillo, Umberto
    Weber, Markus
    Stitah, Sylvie
    Gatlik, Ewa
    Meiser, Karin
    Slade, Alan
    TRANSPLANT INTERNATIONAL, 2011, 24 (03) : 276 - 283
  • [26] De novo malignancies in 1639 consecutive living donor liver transplant recipients
    Tiwari, A.
    Saigal, S.
    Chaudhary, N.
    Saraf, N.
    Saha, S.
    Rastogi, A.
    Goja, S.
    Bhangui, P.
    Nundy, S.
    Soin, A. S.
    TRANSPLANTATION, 2018, 102 : 182 - 183
  • [27] Proposal surveillance protocol for the diagnosis of malignancy de novo in liver transplant recipients
    Mateus, E.
    Figueiredo, I.
    Sousa, M.
    Cardoso, F.
    Bagulho, L.
    Gloria, H.
    Mendes, M.
    Perdigoto, R.
    Pinto Marques, H.
    LIVER TRANSPLANTATION, 2024, 30 : 157 - 157
  • [28] De novo malignancies in liver transplant recipients: A single center experience.
    Rudich, SM
    Hanaway, MJ
    Bebbe, TM
    Alloway, RR
    Gross, TG
    Woodle, S
    Buell, JF
    LIVER TRANSPLANTATION, 2004, 10 (06) : C54 - C54
  • [29] De novo post-transplant malignancies in liver transplantation recipients.
    Boin, IF
    Leonardi, MF
    Ataide, EC
    Leonardi, LS
    LIVER TRANSPLANTATION, 2004, 10 (06) : C15 - C15
  • [30] Unmasking the danger: Investigating factors predisposing liver transplant recipients to invasive fungal infections
    Katheresan, V
    Ramakrishna, Somashekarahosaagrahara
    Malleeswaran, Selvakumar
    Varghese, Joy
    Patcha, Rajanikanth V.
    Kasala, Mohan Babu
    Ellango
    Kumar, Sathish
    Prasanna
    Balachandran, Gayatri
    Reddy, Mettu Srinivas
    TRANSPLANTATION, 2024, 108 (09) : 234 - 234